Technology
Health
Pharmaceutical

Assembly Biosciences

$13.33
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.33 (2.54%) As of 12:03 PM EDT today
+$0.33 (2.54%) Today

Why Robinhood?

You can buy or sell ASMB and other stocks, options, ETFs, and crypto commission-free!

About ASMB

Assembly Biosciences, Inc. Common Stock, also called Assembly Biosciences, is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. Read More It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin on October 7, 2005 and is headquartered in Carmel, IN.

Employees
95
Headquarters
Carmel, Indiana
Founded
2005
Market Cap
332.15M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
246.78K
High Today
$13.38
Low Today
$13.00
Open Price
$13.00
Volume
41.10K
52 Week High
$44.65
52 Week Low
$12.75

Collections

Technology
Health
Pharmaceutical
Biotechnology
Therapy
US
North America

ASMB Earnings

-$1.30
-$0.90
-$0.51
-$0.11
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.